503B outsourcing facility compounded products from central admixture pharmacy services, INC.:1322517 [pots: 20-009478]
Ended Awarded Last action
- Contract number
- 75N90020F00002
- Awardee
-
Central Admixture Pharmacy Services, Inc. UEI NDPWXJSVYVH9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $49,131
Award facts
- Contract value 100% obligated
- $49,130.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92614, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$30,869 | |
| Funding Only Action | -$20,000 | |
| Original award | $100,000 |
About this award
This delivery order, valued at $49,130.55 on a firm fixed-price basis, was awarded to Central Admixture Pharmacy Services, Inc. (Caps) by the NIH Clinical Center on June 15, 2020, for the provision of 503B outsourcing facility compounded pharmaceutical products. The contract was ultimately completed on September 19, 2020. No small business or other set-aside designation was applied to this award. Caps, a large pharmaceutical compounding organization headquartered in Irvine, California, specializes in the preparation and delivery of compounded sterile pharmaceutical preparations including total parenteral nutrition solutions, sterile admixtures, intravenous mixtures, and other customized compounded sterile preparations to federal healthcare agencies. The place of performance is located in Irvine, California.
This delivery order was issued under a larger Indefinite Delivery Contract with the NIH Clinical Center valued at approximately $6 million for 503A and 503B compounded sterile preparations. The administrative de-obligation action documented in this award reflects the standard fiscal year 2021 fund closure procedures required under 31 U.S.C. Section 1552(a), with the period of availability for these fiscal year funds expiring on September 30, 2026. Caps maintains an extensive portfolio of federal healthcare contracts across multiple agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and Department of the Army Medical Command, demonstrating substantial capability and sustained federal demand for specialized pharmaceutical compounding services.
Quick answers
Who was awarded contract 75N90020F00002?
75N90020F00002 was awarded to Central Admixture Pharmacy Services, Inc. by NIH Clinical Center (National Institutes of Health) on June 15, 2020.
How much is contract 75N90020F00002 worth?
The government has obligated $49,131 on 75N90020F00002.
Is contract 75N90020F00002 an order under another contract?
Yes. 75N90020F00002 is a delivery order under 75N90019D00028, an indefinite delivery contract.
Was contract 75N90020F00002 competed?
The extent of competition for 75N90020F00002 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award